DK22688D0 - Polymer-komplekser, fremgangsmaade til fremstilling deraf samt farmaceutiske midler, der indeholder disse komplekser - Google Patents
Polymer-komplekser, fremgangsmaade til fremstilling deraf samt farmaceutiske midler, der indeholder disse komplekserInfo
- Publication number
- DK22688D0 DK22688D0 DK022688A DK22688A DK22688D0 DK 22688 D0 DK22688 D0 DK 22688D0 DK 022688 A DK022688 A DK 022688A DK 22688 A DK22688 A DK 22688A DK 22688 D0 DK22688 D0 DK 22688D0
- Authority
- DK
- Denmark
- Prior art keywords
- complexs
- procedures
- preparing
- pharmaceutical agents
- agents containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6887—Antibody-chelate conjugates using chelates for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/12—Macromolecular compounds
- A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0206—Polyalkylene(poly)amines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Radiology & Medical Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873701665 DE3701665A1 (de) | 1987-01-19 | 1987-01-19 | Polymer-komplexe, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel |
Publications (2)
Publication Number | Publication Date |
---|---|
DK22688D0 true DK22688D0 (da) | 1988-01-19 |
DK22688A DK22688A (da) | 1988-07-20 |
Family
ID=6319226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK022688A DK22688A (da) | 1987-01-19 | 1988-01-19 | Polymer-komplekser, fremgangsmaade til fremstilling deraf samt farmaceutiske midler, der indeholder disse komplekser |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0277088A2 (da) |
JP (1) | JPS6454028A (da) |
AU (1) | AU1064988A (da) |
DE (1) | DE3701665A1 (da) |
DK (1) | DK22688A (da) |
IE (1) | IE880127L (da) |
IL (1) | IL85139A0 (da) |
NO (1) | NO880179L (da) |
PT (1) | PT86572B (da) |
ZA (1) | ZA88342B (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681543A (en) * | 1988-02-29 | 1997-10-28 | Shering Aktiengesellschaft | Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI |
DE3806795A1 (de) * | 1988-02-29 | 1989-09-07 | Schering Ag | Polymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
GB8900719D0 (en) * | 1989-01-13 | 1989-03-08 | Nycomed As | Compounds |
FR2645862B1 (fr) * | 1989-04-18 | 1991-07-12 | Esteve Labor Dr | Derives d'isothiazolo-pyrydone azetidinyl substitues, leur preparation et leur application en tant que medicaments |
US5384108A (en) * | 1989-04-24 | 1995-01-24 | Mallinckrodt Medical, Inc. | Magnetic resonance imaging agents |
GB8916781D0 (en) * | 1989-07-21 | 1989-09-06 | Nycomed As | Compositions |
DE3938992A1 (de) | 1989-11-21 | 1991-05-23 | Schering Ag | Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
DE4017439C2 (de) * | 1990-05-30 | 1994-06-23 | Deutsches Krebsforsch | Polyethersubstituierte Tumormittel |
DE4039920A1 (de) * | 1990-12-14 | 1992-06-17 | Basf Ag | Neue polyethylenimin- und polyvinylamin-derivate, mit diesen derivaten beschichtete traegermaterialien auf der basis von aluminium sowie deren verwendung zur herstellung von offsetdruckplatten |
JP2901787B2 (ja) * | 1991-07-15 | 1999-06-07 | 日本メジフィジックス株式会社 | 核磁気共鳴造影剤 |
JP2894879B2 (ja) * | 1991-10-04 | 1999-05-24 | 日本メジフィジックス株式会社 | 診断用造影剤 |
US5324503A (en) * | 1992-02-06 | 1994-06-28 | Mallinckrodt Medical, Inc. | Iodo-phenylated chelates for x-ray contrast |
AU5355094A (en) * | 1992-10-14 | 1994-05-09 | Sterling Winthrop Inc. | Therapeutic and diagnostic imaging compositions and methods |
EP1419786A1 (en) | 2002-11-13 | 2004-05-19 | Bracco Imaging S.p.A. | Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof |
ITPD20030174A1 (it) * | 2003-07-31 | 2003-10-29 | Univ Padova | Coniugati polimerici per diagnostica e terapia |
DE102005039154A1 (de) * | 2005-08-17 | 2007-03-01 | GÖPFERICH, Achim, Prof. Dr. | Bioabbaubare Polymere für den Transport von Nukleinsäuren in Zellen |
JP2023525544A (ja) | 2020-05-12 | 2023-06-16 | ビーエーエスエフ ソシエタス・ヨーロピア | 分散剤としてのリジンのカルボキシメチル化ポリマーの使用及びそれを含む組成物 |
-
1987
- 1987-01-19 DE DE19873701665 patent/DE3701665A1/de not_active Withdrawn
-
1988
- 1988-01-18 NO NO880179A patent/NO880179L/no unknown
- 1988-01-18 EP EP88730013A patent/EP0277088A2/de not_active Withdrawn
- 1988-01-19 IE IE880127A patent/IE880127L/xx unknown
- 1988-01-19 DK DK022688A patent/DK22688A/da not_active Application Discontinuation
- 1988-01-19 IL IL85139A patent/IL85139A0/xx unknown
- 1988-01-19 PT PT86572A patent/PT86572B/pt not_active IP Right Cessation
- 1988-01-19 ZA ZA880342A patent/ZA88342B/xx unknown
- 1988-01-19 JP JP63007661A patent/JPS6454028A/ja active Pending
- 1988-01-19 AU AU10649/88A patent/AU1064988A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO880179L (no) | 1988-07-20 |
JPS6454028A (en) | 1989-03-01 |
PT86572A (de) | 1988-02-01 |
AU1064988A (en) | 1988-07-21 |
PT86572B (pt) | 1991-12-31 |
NO880179D0 (no) | 1988-01-18 |
IL85139A0 (en) | 1988-06-30 |
DK22688A (da) | 1988-07-20 |
ZA88342B (en) | 1988-07-04 |
DE3701665A1 (de) | 1988-07-28 |
EP0277088A2 (de) | 1988-08-03 |
IE880127L (en) | 1988-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK654589A (da) | Heterocykliske derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne | |
NO904584D0 (no) | Preparater inneholdende hyaluronsyreforbindelser samt fremgangsmaate for fremstilling derav. | |
DK22688D0 (da) | Polymer-komplekser, fremgangsmaade til fremstilling deraf samt farmaceutiske midler, der indeholder disse komplekser | |
DK128688A (da) | Thiazolderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne | |
DK219387A (da) | Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DK276189A (da) | Polypeptidforbindelser, fremgangsmaader til fremstilling heraf farmaceutiske midler indeholdende disse | |
DK378988A (da) | Dopamin-beta-hydroxylaseinhibitorer, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse forbindelser | |
DK642588D0 (da) | Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme | |
DK486789D0 (da) | Benzoxazolinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DK392284A (da) | Lh-rh-antagonister og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende disse | |
DK66086A (da) | Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
DK162600C (da) | Oe4-(2-hydroxycyklohexylmethyl)phenylaaalkansyrederivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DK567188D0 (da) | 2,2-dimethylchromenderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne | |
DK170788A (da) | Dihydropyridazinonderivater, fremgangsmaader til fremstilling heraf samt laegemidler indeholdende disse | |
DK469189A (da) | Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme | |
DK307085A (da) | 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DK567184A (da) | Pyridonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DK2488D0 (da) | Dopamin-beta-hydroxylaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse | |
DK65986A (da) | Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
DK166686A (da) | Phosphinforbindelser, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse forbindelser | |
DK268889A (da) | Cykliske d-cys6-peptidforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
DK165978C (da) | 1-aminoethyl-1h-imidazolderivater, fremgangsmaader til fremstilling deraf samt antimykotiske midler indeholdende disse | |
DK379287D0 (da) | 1,3-propandiaminderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DK564284D0 (da) | Pyrazinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DK361189A (da) | Allylaminoethylazoler, fremgangsmaade til fremstilling deraf samt fungicider og antimykotiske midler indeholdende disse forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |